Met overexpression in HCC827 GR5 lung cancer cells renders them insensitive to gefitinib-mediated inhibition of the PI3K/Akt and MEK/ERK pathways and gefitinib-induced apoptosis compared to HCC827 parental cells [18]. The gene discussed is AKT1; the disease is lung cancer.